Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 103 publications
Detection and warning of drug-induced hypomagnesemia: a pharmacovigilance study of the FDA Adverse Event Reporting System.
Journal: Magnesium research
Published: September 26, 2025
ORCHARD: Osimertinib Plus Necitumumab in Patients With Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer With a Secondary Epidermal Growth Factor Receptor Alteration Whose Disease Had Progressed on First-Line Osimertinib.
Journal: JCO precision oncology
Published: June 04, 2025
A Case of EGFR-mutant Squamous Cell Lung Cancer Treated With Necitumumab Combination Therapy.
Journal: In vivo (Athens, Greece)
Published: December 01, 2024
Clinical impact of hypomagnesemia induced by necitumumab plus cisplatin and gemcitabine treatment in patients with advanced lung squamous cell carcinoma: a subanalysis of the NINJA study.
Journal: Therapeutic advances in medical oncology
Published: October 16, 2024
Transforming Lung Cancer Management: A Promising Case Study of Immune Checkpoint Inhibitor Success Following a Multidisciplinary Approach.
Journal: Diagnostics (Basel, Switzerland)
Published: August 30, 2024
Effects of N361 Glycosylation on Epidermal Growth Factor Receptor Biological Function.
Journal: bioRxiv : the preprint server for biology
Published: July 29, 2024
Skin disorder within 30 days is a favorable prognostic factor in patients with lung squamous cell carcinoma treated with necitumumab plus gemcitabine and cisplatin: a sub-analysis of the NINJA study.
Journal: Therapeutic advances in medical oncology
Published: July 10, 2024
Afatinib and Necitumumab in EGFR-Mutant NSCLC with Acquired Resistance to Tyrosine Kinase Inhibitors.
Journal: JTO clinical and research reports
Published: May 16, 2024
Enhancing Neutrophil Cytotoxicity of a Panel of Clinical EGFR Antibodies by Fc Engineering to IgA3.0.
Journal: Molecular cancer therapeutics
Published: March 26, 2024
A Case of Advanced Biliary Tract Cancer With EGFR Amplification That Responded to Necitumumab.
Journal: Cancer reports (Hoboken, N.J.)
Published: February 14, 2024
Enhancement of Antitumor Effect by the Combined Use of Anti-EGFR Antibody(Necitumumab)and PD-1 Inhibitor
Journal: Gan to kagaku ryoho. Cancer & chemotherapy
Published: January 22, 2024
Multicenter, Retrospective Study to Evaluate Necitumumab Plus Cisplatin and Gemcitabine After Immune Checkpoint Inhibitors in Advanced Squamous Cell Lung Cancer in Japan: The NINJA Study.
Journal: JTO clinical and research reports
Published: June 28, 2023
Last Updated: 10/31/2025